Search

Your search keyword '"Maffucci, Tania"' showing total 212 results

Search Constraints

Start Over You searched for: Author "Maffucci, Tania" Remove constraint Author: "Maffucci, Tania"
212 results on '"Maffucci, Tania"'

Search Results

2. An Overview of Class II Phosphoinositide 3-Kinases

5. Supplementary Figures S1, S2, S3, S4, S5 from Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in Melanoma

6. Data from Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in Melanoma

7. Supplementary Figure Legends 1-5 from Phospholipase Cγ1 Is Required for Metastasis Development and Progression

8. Supplementary Figure 5 from Phospholipase Cγ1 Is Required for Metastasis Development and Progression

9. Data from Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway by Inositol Pentakisphosphate Results in Antiangiogenic and Antitumor Effects

10. Supplementary Fig. S2 from Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway by Inositol Pentakisphosphate Results in Antiangiogenic and Antitumor Effects

11. Supplementary Figure 2 from Phospholipase Cγ1 Is Required for Metastasis Development and Progression

12. Supplementary Figure 1 from Phospholipase Cγ1 Is Required for Metastasis Development and Progression

13. Supplementary Figure 3 from Phospholipase Cγ1 Is Required for Metastasis Development and Progression

15. Supplementary Figure 4 from Phospholipase Cγ1 Is Required for Metastasis Development and Progression

20. Regulation of human trophoblast gene expression by endogenous retroviruses

23. Proteome and functional decline as platelets age in the circulation

24. Proteome and functional decline as platelets age in the circulation

25. A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis

26. A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis

28. Growth and Viability of Cutaneous Squamous Cell Carcinoma Cell Lines Display Different Sensitivities to Isoform-Specific Phosphoinositide 3-Kinase Inhibitors

29. Profiling the eicosanoid networks that underlie the anti- and pro-thrombotic effects of aspirin

30. A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis.

31. A novel genetic variant inPTGS1affects N‐glycosylation of cyclooxygenase‐1 causing a dominant‐negative effect on platelet function and bleeding diathesis

37. Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy

38. Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in Melanoma

39. MOESM3 of Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growth

40. Additional file 1: of Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer

42. A novel genetic variant in PTGS1 affects N‐glycosylation of cyclooxygenase‐1 causing a dominant‐negative effect on platelet function and bleeding diathesis.

43. Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119

Catalog

Books, media, physical & digital resources